die nächsten 500% sind gestern in USA gestartet !!!! - 500 Beiträge pro Seite

[WillyderErste]

Patch Intl getsern 40% im plus geschlossenen, australische tochter Pharmaxis geht an die NASDAQ beide aktien strong buy !!!!

[WillyderErste]

Heute wider plus 30%

[WillyderErste]

heute wieder plus 10%

[WillyderErste]

Patch provides current activities update
Friday August 26, 1:20 pm ET


VANCOUVER, Aug. 26 /PRNewswire-FirstCall/ - Patch International Inc. (PTII: OTCBB) is extremely pleased to report that it has been informed by the operator that the W5M Mcleod well is now scheduled to be fraced on Sunday August 28, 2005. This well was originally scheduled to be fraced several weeks earlier, however unexpected delays occurred that were out of PTII`s control.
ADVERTISEMENT



PTII is also pleased to report that the clinical trials that are currently being conducted for the treatment of cystic fibrosis are proceeding ahead of schedule and the results from these landmark clinical trials are now expected next week.

David Stadnyk, President of PTII said, "These are two highly important events in the progression of PTII. The operator at the Mcleod well remains very confident of a commercial well from the property and if the operator moves to complete the well the resulting impact to PTII`s cash flow will be extremely positive. We have enjoyed a phenomenal growth rate from our share ownership in our pharmaceutical investment and we would expect that the value of our investment to receive a significant boost from successful clinical results next week."

[WillyderErste]

Patch investment scores resounding success with positive results from cystic fibrosis trials
Wednesday August 31, 10:51 am ET


VANCOUVER, Aug. 31 /PRNewswire-FirstCall/ - Patch International Inc. (PTII: OTCBB) is extremely pleased to report that it has been informed by the management of its pharmaceutical investment, Pharmaxis (ASX: PXS, NASDAQ NM: PXSL), that excellent results from its Phase II trial, DPM-CF-201, in patients with cystic fibrosis have been received.
ADVERTISEMENT


The trial achieved its primary end point of improvement in lung function as measured by FEV(1). At the end of the two-week treatment periods, patients receiving Bronchitol had statistically significantly improved lung function compared to two weeks of placebo treatment. Spirometry was used to assess lung function.

David Stadnyk, President of PTII said, "Reaching this milestone represents a tremendous stamp of validation, and the company can look forward to the results from additional studies in the future. PTII plans to build upon this success with opportunities of greater magnitude in both the domestic and international oil and gas sectors and is looking forward to an active period of news and company development activities."

The study was a double blind, placebo controlled, radomised comparison of 420mg of Bronchitol to placebo in 49 patients with cystic fibrosis at 8 centers across Australia and New Zealand. Bronchitol or placebo was administered twice a day for 14 days in a crossover design.

Secondary endpoints of the study include quality of life measures. Significantly better respiratory symptoms were achieved among patients when taking Bronchitol compared to when on placebo. Additionally, Bronchitol had no deleterious effect on the microbiology of the sputum.

No serious adverse events were related to Bronchitol use.

Pharmaxis has received Orphan Drug status from the Food and Drug administration (FDA) for Bronchitol in cystic fibrosis.

Pharmaxis plans to present additional data from the study at the internationally important 19th Annual North American Cystic Fibrosis Conference to be held in Baltimore, MD in October.

For more information about Pharmaxis and the positive cystic fibrosis trial results, go to www.pharmaxis.com.au.

ABOUT PATCH INTERNATIONAL

PTII is a junior oil and gas producer that currently earns oil revenue from 19 oil wells. These wells provide the company with both short-term and long-term cash flow. It is anticipated that these wells will have a life of over 15 years. PTII has properties in North America and is exploring opportunities in North Africa, South America, and Ukraine. PTII holds 11.2 million shares in Pharmaxis (Australian Stock Exchange: PXS, NASDAQ NM: PXSL) of which 5.6 million have been declared as a dividend, and is largest shareholder behind the Rothschild Group. PTII plans to use the proceeds from this investment to build the company`s oil and gas assets and just as PTII`s pioneering pharmaceutical efforts are coming to fruition, PTII believes that the coming months will be a period of tremendous success for the company`s domestic and international oil and gas prospects.

For further information visit our corporate website at www.patchinternational.com.

If you are not currently on the PTII updates list, please send in your email to [e-mail] or call 888 864 7372 with the best way to keep you informed. We will send out regular updates and news releases to everyone who asks to be on the list.




heute wieder plus 15%

[WillyderErste]

VANCOUVER, Sept. 13 /PRNewswire-FirstCall/ - Patch International Inc. (PTII: OTCBB) today announced the impressive initial results from the completion of its W5M Mcleod oil well discovery in the Edson area of Alberta, Canada.
ADVERTISEMENT


The well flowed at a rate of approximately 250-300 barrels of oil (38 degrees API) per day based on a 24-hour production test. The testing showed outstanding oil recovery results with the last swab recoveries being 99% oil and 1% water. The well has now been shut-in for pressure build-up. The operator has informed PTII that full production from the well is expected before the end of the month.

Commenting on the major oil discovery, David Stadnyk, PTII`s President and Chief Executive Officer said, "Today`s success is a major step forward for PTII as the Company continues to execute on its strategies of growing its domestic oil and gas revenues as well as evaluating and selecting opportunistic asset acquisitions. I am delighted that another of our North American exploration projects has begun to yield results and I am looking forward to rapid growth in our oil and gas business."

The Mcleod Project is a W5M - west of the fifth meridian property and PTII is participating for a 10% working interest. The first well had been successfully logged with positive results. Casing has been cemented to a total depth of 1939 TVD meters. The operator received very good porosity readings, positive log results, and all indications were very promising. Log results indicated that a commercial gas well was anticipated from the key target zone - the Ellerslie zone - and that a second key oil zone - the Basal Belly River zone - could be commercially viable as well. Today`s outstanding results from the Basel Belly River zone confirm the commercial oil well success and further testing may confirm commercial gas well success from the Basel Belly River zone as well. Further plans for the Ellerslie gas zone will be provided as they materialize.

[WillyderErste]

September 29, 2005 (AllPennyStocks.com Media, Inc.) - The oil and gas industry - from the way it behaved in the aftermath of the year`s twin disasters named Rita and Katrina - has had obstacles to overcome both on the PR and production side. World events and shortages in refining have caused prices to take an unorthodox rise. Though this might be unfortunate to the general public, investors in these types of companies have been able to see some benefit in these particular markets.

One company that may have less trouble filling the ranks of its fan club is Vancouver-based Patch International, a junior oil and gas producer, currently drawing revenue from 19 wells in Saskatchewan. Company literature claims these wells provide both short-term and long-term cash flow. The firm is currently exploring opportunities beyond its Canadian backyard to include Algeria, Tunisia, Libya and Ukraine. Soaring global demand for petroleum, in response to global trouble (both natural and man-made) has positioned Patch to capitalize on global energy projects - particularly in the areas just mentioned, where the petroleum discoveries can provide maximum return on investment.


(more below...)



--------------------------------------------------------------------------------



--------------------------------------------------------------------------------






Patch`s growth strategy is a fairly simple one: to engage in joint ventures with worldwide energy companies, acquiring properties in energy sectors with high growth potential, and partnering with emerging energy companies sharing Patch`s global perspective. (No dilution to finance these activities should be required as Patch`s investment in Pharmaceutical investment has grown to $25 million US)

Among Patch`s management team, David Stadnyk is president and CEO, a 20-year veteran of management and corporate finance. His diverse interests include media, sports management, and of course, the resource sector with not only Patch International, but also Goanna Resources, with whom he wears many hats. He was a founder of Praxis (now Pharmaxis), which has grown from $200 thousand to $25 million for Patch. His goal is to turn $10 million into $100 million in the oil and gas sector with Patch. Just recently, Arun Dey signed on as senior executive vice president and chief operating officer. The founder of Dako Energy in 2002, Dey previously had been with Alberta Energy Company for 18 years.

Two oil properties commenced work in the first half of 2005 in the neighbouring province of Alberta, one at Bear Canyon in March; the other, more recently at W5M McLeod near Edson in mid-September. Tests on the latter turned out remarkably well, with approximately 250-300 barrels of oil per day. Full production should have commenced by the end of the month, good news for an industry given the jitters about supply.

Patch is ahead of some of its competitors in punching holes in the W5M property and should deliver results of that effort soon through it all, Patch`s shares have not decreased in value, unlike those competitors, making it an attractive investment.

As indicated above, Patch International is active beyond its borders and North America`s borders. Visits to Europe and North Africa by Patch have solidified relationships with Algerian and Libyan government officials to continue negotiations for various energy projects.

What probably makes a petroleum company like Patch unique is that it is also a heavy investor in the Australian pharmaceutical company Pharmaxis, in which it has more than 11 million shares (half of which have been declared as a dividend), and is the largest shareholder behind the Rothschild Group. The market value of these shares is currently over $20 million USD. Patch plans to use the proceeds from this investment to bolster its oil and gas assets just as Pharmaxis` drug discoveries are coming to fruition.

A recent development with Pharmaxis, incidentally, is that it is now in Phase II tests on a new inhaled drug aimed at fighting chronic obstructive pulmonary disease (COPD). The drug is called Aridol, and the tests are being conducted throughout Australia on about 140 patients over the next three months or so. Investors will avidly await news on these tests. Additionally, this week Pharmaxis announced a global capital raising led by CIBC World Markets Corp. and Wilson HTM Corporate Finance Ltd.in Australia that could bring over $100 million AUS into the company.

In July, Patch International underwent a 10-to-one stock consolidation, by which 100,000,000 common shares became 10,000,000 with a par value of $0.001. It was also on July 25 that Patch`s stock symbol changed from PAII to PTII.

Not to suggest that some investors may have missed the boat, but if they`d noticed this stock and taken the plunge around this time last year, they`d have doubled their money. After languishing around 40 cents (all values in U.S. funds unless specified otherwise) post stock-split in early February, the price shot up to peak at $1.75 at the end of August, which also was their 52 week high before settling in around $1.60 toward the end of a very difficult September for the oil and gas industry.

With its improving prospects at wells worldwide, its finger in yet another lucrative pie, and volatility in world events, (translating to volatility in the petroleum industry), Patch should provide investors a breath of fresh air, and could prove a welcome addition to a small cap portfolio